Selective inhibition of sheep kidney 11β-hydroxysteroid dehydrogenase isoform 2 activity by 5α-reduced (but not 5β) derivatives of adrenocorticosteroids
- 28 February 1997
- Vol. 62 (2) , 230-237
- https://doi.org/10.1016/s0039-128x(96)00208-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excessJournal of Clinical Endocrinology & Metabolism, 1995
- Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenaseNature Genetics, 1995
- Expression of 11β-OHSD along the nephron of mammals and humansSteroids, 1994
- The “Mineralocorticoid-Like” Actions Conferred on Corticosterone by Carbenoxolone Are Inhibited by the Mineralocorticoid Receptor (Type I) Antagonist RU28318*Endocrinology, 1991
- ll?-Hydroxysteroid Dehydrogenase Activity in the Renal Target Cells of Aldosterone*Endocrinology, 1991
- THE ANTINATRIURETIC AND KALIURETIC EFFECTS OF THE GLUCOCORTICOIDS CORTICOSTERONE AND CORTISOL FOLLOWING PRETREATMENT WITH CARBENOXOLONE SODIUM (A LIQUORICE DERIVATIVE) IN THE ADRENALECTOMIZED RATEndocrinology, 1989
- Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, MediatedScience, 1988
- LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTORThe Lancet, 1988
- A Syndrome of Apparent Mineralocorticoid Excess Associated with Defects in the Peripheral Metabolism of Cortisol*Journal of Clinical Endocrinology & Metabolism, 1979
- AN ABNORMALITY IN STEROID REDUCTIVE METABOLISM IN A HYPERTENSIVE SYNDROMEJournal of Clinical Endocrinology & Metabolism, 1977